{"id":60670,"date":"2025-01-23T13:02:32","date_gmt":"2025-01-23T12:02:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/"},"modified":"2025-01-23T13:02:32","modified_gmt":"2025-01-23T12:02:32","slug":"kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/","title":{"rendered":"Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025"},"content":{"rendered":"
\n

SKILLMAN, N.J.–(BUSINESS WIRE)–Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast of the conference call can also be accessed at investors.kenvue.com<\/a>, with a replay made available after the live event.<\/p>\n

\nAbout Kenvue<\/span><\/b><\/p>\n

\nKenvue Inc. is the world\u2019s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno\u00ae<\/sup>, BAND-AID\u00ae<\/sup> Brand, Johnson\u2019s\u00ae<\/sup>, Listerine\u00ae<\/sup>, Neutrogena\u00ae<\/sup> and Tylenol\u00ae<\/sup>, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers\u2019 hands and earn a place in their hearts and homes. Learn more at www.kenvue.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations:<\/b>
Sofya Tsinis
\n
Kenvue_IR@Kenvue.com<\/a><\/p>\n

\nMedia Relations:<\/b>
Melissa Witt
\n
Media@Kenvue.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SKILLMAN, N.J.–(BUSINESS WIRE)–Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60670","6":"format-standard","7":"category-industry"},"yoast_head":"\nKenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SKILLMAN, N.J.–(BUSINESS WIRE)–Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-23T12:02:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250123211823\/en\/1778436\/22\/Kenvue_Logo_Black.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025\",\"datePublished\":\"2025-01-23T12:02:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\\\/\"},\"wordCount\":200,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250123211823\\\/en\\\/1778436\\\/22\\\/Kenvue_Logo_Black.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\\\/\",\"name\":\"Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250123211823\\\/en\\\/1778436\\\/22\\\/Kenvue_Logo_Black.jpg\",\"datePublished\":\"2025-01-23T12:02:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250123211823\\\/en\\\/1778436\\\/22\\\/Kenvue_Logo_Black.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250123211823\\\/en\\\/1778436\\\/22\\\/Kenvue_Logo_Black.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/","og_locale":"en_US","og_type":"article","og_title":"Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025 - Pharma Trend","og_description":"SKILLMAN, N.J.–(BUSINESS WIRE)–Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/","og_site_name":"Pharma Trend","article_published_time":"2025-01-23T12:02:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250123211823\/en\/1778436\/22\/Kenvue_Logo_Black.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025","datePublished":"2025-01-23T12:02:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/"},"wordCount":200,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250123211823\/en\/1778436\/22\/Kenvue_Logo_Black.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/","url":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/","name":"Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250123211823\/en\/1778436\/22\/Kenvue_Logo_Black.jpg","datePublished":"2025-01-23T12:02:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250123211823\/en\/1778436\/22\/Kenvue_Logo_Black.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250123211823\/en\/1778436\/22\/Kenvue_Logo_Black.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/kenvue-to-announce-fourth-quarter-and-full-year-2024-results-on-february-6-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Kenvue to Announce Fourth Quarter and Full Year 2024 Results on February 6, 2025"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60670"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60670\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}